BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 35887072)

  • 1. The NEL Family of Bacterial E3 Ubiquitin Ligases.
    Bullones-Bolaños A; Bernal-Bayard J; Ramos-Morales F
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificities and redundancies in the NEL family of bacterial E3 ubiquitin ligases of
    Bullones-Bolaños A; Martín-Muñoz P; Vallejo-Grijalba C; Bernal-Bayard J; Ramos-Morales F
    Front Immunol; 2024; 15():1328707. PubMed ID: 38361917
    [No Abstract]   [Full Text] [Related]  

  • 3. Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation.
    Pisano A; Albano F; Vecchio E; Renna M; Scala G; Quinto I; Fiume G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of catalysis, E2 recognition, and autoinhibition for the IpaH family of bacterial E3 ubiquitin ligases.
    Keszei AF; Sicheri F
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1311-1316. PubMed ID: 28115697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hijacking the host ubiquitin pathway: structural strategies of bacterial E3 ubiquitin ligases.
    Hicks SW; Galán JE
    Curr Opin Microbiol; 2010 Feb; 13(1):41-6. PubMed ID: 20036613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial E3 ligase effectors exploit host ubiquitin systems.
    Ashida H; Sasakawa C
    Curr Opin Microbiol; 2017 Feb; 35():16-22. PubMed ID: 27907841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ralstonia solanacearum novel E3 ubiquitin ligase (NEL) effectors RipAW and RipAR suppress pattern-triggered immunity in plants.
    Nakano M; Oda K; Mukaihara T
    Microbiology (Reading); 2017 Jul; 163(7):992-1002. PubMed ID: 28708051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of NopM, a novel E3 ubiquitin ligase (NEL) domain effector of Rhizobium sp. strain NGR234.
    Xin DW; Liao S; Xie ZP; Hann DR; Steinle L; Boller T; Staehelin C
    PLoS Pathog; 2012; 8(5):e1002707. PubMed ID: 22615567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases.
    Rohde JR; Breitkreutz A; Chenal A; Sansonetti PJ; Parsot C
    Cell Host Microbe; 2007 Mar; 1(1):77-83. PubMed ID: 18005683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight into the recognition of the linear ubiquitin assembly complex by Shigella E3 ligase IpaH1.4/2.5.
    Hiragi K; Nishide A; Takagi K; Iwai K; Kim M; Mizushima T
    J Biochem; 2023 Mar; 173(4):317-326. PubMed ID: 36610722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin.
    Bernal-Bayard J; Ramos-Morales F
    J Biol Chem; 2009 Oct; 284(40):27587-95. PubMed ID: 19690162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases.
    Quezada CM; Hicks SW; Galán JE; Stebbins CE
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4864-9. PubMed ID: 19273841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ubiquitin ligation machinery in the defense against bacterial pathogens.
    Tripathi-Giesgen I; Behrends C; Alpi AF
    EMBO Rep; 2021 Nov; 22(11):e52864. PubMed ID: 34515402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ralstonia solanacearum type III effector RipV2 encoding a novel E3 ubiquitin ligase (NEL) is required for full virulence by suppressing plant PAMP-triggered immunity.
    Cheng D; Zhou D; Wang Y; Wang B; He Q; Song B; Chen H
    Biochem Biophys Res Commun; 2021 Apr; 550():120-126. PubMed ID: 33691198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems.
    Angot A; Vergunst A; Genin S; Peeters N
    PLoS Pathog; 2007 Jan; 3(1):e3. PubMed ID: 17257058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of the host ubiquitome by bacterial enzymes.
    Berglund J; Gjondrekaj R; Verney E; Maupin-Furlow JA; Edelmann MJ
    Microbiol Res; 2020 May; 235():126429. PubMed ID: 32109687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pathogen type III effector with a novel E3 ubiquitin ligase architecture.
    Singer AU; Schulze S; Skarina T; Xu X; Cui H; Eschen-Lippold L; Egler M; Srikumar T; Raught B; Lee J; Scheel D; Savchenko A; Bonas U
    PLoS Pathog; 2013 Jan; 9(1):e1003121. PubMed ID: 23359647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation.
    de Jong MF; Liu Z; Chen D; Alto NM
    Nat Microbiol; 2016 May; 1(7):16084. PubMed ID: 27572974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and phenotypic analysis of SspH1 identifies a new Salmonella effector, SspH3.
    Herod A; Emond-Rheault JG; Tamber S; Goodridge L; Lévesque RC; Rohde J
    Mol Microbiol; 2022 Apr; 117(4):770-789. PubMed ID: 34942035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of bacterial manipulation of the host ubiquitin pathways.
    Zhou Y; Zhu Y
    Cell Microbiol; 2015 Jan; 17(1):26-34. PubMed ID: 25339545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.